Precision Medicine and Health Consortium (PMHC)

The Precision Medicine and Health Consortium capitalizes on the expertise within the scientific community, health systems, payor industry and others to make novel discoveries and therapeutic advances in precision medicine, and translate these to improve healthcare. 

The PMHC joins together faculty with a common purpose and connects faculty with expertise in precision medicine to address health problems using an interdisciplinary approach. It is our belief that a interdisciplinary group will more quickly advance research, educational, and outreach activities.

Members of the PMHC also bridge the gap between genetic research discoveries and application in patient care. Precision Medicine is a national priority and this group strives to keep on the forefront of this evolving field.

Latest News

U-PGx: Treatment Optimization Accessible to Every European Citizen

U-PGx logoA new project titled "U-PGx" aims to make effective treatment optimization accessible to every European citizen. The U-PGx consortium will examine whether pre-emptive genotyping of an entire panel of genetic markers is cost-effective and results in a better outcome for patients.

CPIC Guideline Videos Available

CPIC logoA new resource is available on PharmGKB to help researchers and clinicians more easily and quickly understand CPIC recommendations and how to find supporting information on the PharmGKB website.

Exceptional Response’ to First-Line Vismodegib Reported in Patient With Unresectable/Multifocal Adult Medulloblastoma

brainThe ASCO Post highlighted the extraordinary response to targeted therapy of a patient with an adult medulloblastoma brain tumor, the first such report in the first-line setting using hedgehog inhibitor vismodegib (Erivedge).  The case report was published in 

U of M Grand Challenge Collaboration Research Grant Awarded to Precision Medicine

DNA strands"Minnesota Precision Medicine Collaborative: Transforming health and advancing equity," was named one of eight U of M Grand Challenges Research collaboration grants to advance the research goals of the TC Campus Strategic Plan over the next ten years.

U of M Grand Challenges Exploratory Research Grants Awarded to Precision Medicine

dessertDevelopment of a clinical precision medicine program in ovarian cancer as a paradigm for 21st century tailored health care solutions 

NIH: Survey shows broad support for national precision medicine study

National Institutes of Health logoIn a recent survey designed to measure public attitudes about the Precision Medicine Initiative (PMI) Cohort Program, a majority of respondents expressed willingness to participate in the nationwide research effort. 

Prof. Susan M. Wolf Awarded NIH Grant for Project to Establish the Legal Framework for Genomic Medicine

Susan WolfThe National Institutes of Health (NIH) has awarded the first-ever grant dedicated to laying the policy groundwork needed to translate genomic medicine into clinical application. Professor Susan M.

Pages

Pharmacogenomics Conference

Genomic Testing to Individualize Drug Therapy

Register Now!
June 22, 2018  -  7am-5pm
McNamara Alumni Center
University of Minnesota

Upcoming Seminars

Presented by The Minnesota Precision Medicine Collaborative

APRIL 6, 2018
Cardiovascular Epigenomics: From Chromatin Fiber to Human Populations

Thomas M. Vondriska, PhD
Professor of Anesthesiology, Medicine and
Physiology, David Geffen School of Medicine at UCLA

2:00 PM | 5-125 Moos Tower (TC); 302 Heller Hall (Duluth via ITV)

Join our Google Group

Join our Google Group to receive Precision Medicine and Health Consortium communications.

21st Century Cures Initiative Passed

Congress passed the 21st Century Cures Initiative, a $6.3 billion medical research bill. The bill authorizes significant funding for various health care related programs over the next 10 years, including $1.5 billion for Obama's Precision Medicine Initiative.

Links

2016 Precision Medicine Conference presentation videos

Genomics and Health Impact Weekly Scan  This weekly update features emerging roles of human genomics, testing and interventions in a wide variety of noncommunicable diseases across the life span.

Contact Us

Pamala Jacobson, PharmD
pmhconso@umn.edu